EXPANDED TARGET DRUG DISCOVERY
DEAD

Serial Number

75908407

Owner

Novasite Pharmaceuticals, Inc.

Attorney

CATHRYN A. CAMPBELL

First Use Date

Nov 26, 2001

Filing Date

Feb 2, 2000

Add to watchlist:

No watchlists yet
View on USPTO

EXPANDED TARGET DRUG DISCOVERY Trademark

Serial Number: 75908407

EXPANDED TARGET DRUG DISCOVERY is a trademark filed by Novasite Pharmaceuticals, Inc. on February 2, 2000. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Novasite Pharmaceuticals, Inc. (4 trademarks)

3520 Dunhill Street
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

February 2, 2000

Registration Date

Not Registered

First Use Anywhere

November 26, 2001

First Use in Commerce

November 26, 2001

Published for Opposition

May 22, 2001

Filing History

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 20, 2004 ABN2
ASSIGNED TO EXAMINER
Jan 16, 2004 DOCK
CASE FILE IN TICRS
Nov 21, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2003 CRFA
PAPER RECEIVED
Oct 20, 2003 MAIL
NON-FINAL ACTION MAILED
Apr 22, 2003 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 4, 2002 SUPC
USE AMENDMENT FILED
Dec 21, 2001 IUAF
NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 14, 2001 NOAM
PUBLISHED FOR OPPOSITION
May 22, 2001 PUBO
NOTICE OF PUBLICATION
May 9, 2001 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2001 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2001 CRFA
NON-FINAL ACTION MAILED
Jul 5, 2000 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2000 DOCK
ASSIGNED TO EXAMINER
Jun 28, 2000 DOCK